197 related articles for article (PubMed ID: 27313333)
1. Plasma miR-10a: A Potential Biomarker for Coronary Artery Disease.
Luo L; Chen B; Li S; Wei X; Liu T; Huang Y; Lin X
Dis Markers; 2016; 2016():3841927. PubMed ID: 27313333
[TBL] [Abstract][Full Text] [Related]
2. Altered Plasma miR-144 as a Novel Biomarker for Coronary Artery Disease.
Chen B; Luo L; Wei X; Gong D; Jin L
Ann Clin Lab Sci; 2018 Jul; 48(4):440-445. PubMed ID: 30143484
[TBL] [Abstract][Full Text] [Related]
3. Plasma MicroRNA-126-5p is Associated with the Complexity and Severity of Coronary Artery Disease in Patients with Stable Angina Pectoris.
Li HY; Zhao X; Liu YZ; Meng Z; Wang D; Yang F; Shi QW
Cell Physiol Biochem; 2016; 39(3):837-46. PubMed ID: 27497911
[TBL] [Abstract][Full Text] [Related]
4. Expression of miR-126 and its potential function in coronary artery disease.
Wang X; Lian Y; Wen X; Guo J; Wang Z; Jiang S; Hu Y
Afr Health Sci; 2017 Jun; 17(2):474-480. PubMed ID: 29062343
[TBL] [Abstract][Full Text] [Related]
5. Plasma vaspin concentrations are decreased in acute coronary syndrome, but unchanged in patients without coronary lesions.
Zhang B; Peng W; Li H; Lu Y; Zhuang J; Wang K; Su Y; Xu Y
Clin Biochem; 2013 Oct; 46(15):1520-5. PubMed ID: 23850850
[TBL] [Abstract][Full Text] [Related]
6. Circulating Extracellular miRNA Analysis in Patients with Stable CAD and Acute Coronary Syndromes.
Zhelankin AV; Stonogina DA; Vasiliev SV; Babalyan KA; Sharova EI; Doludin YV; Shchekochikhin DY; Generozov EV; Akselrod AS
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209965
[TBL] [Abstract][Full Text] [Related]
7. Alteration of circulating miRNAs during myocardial infarction and association with lipid levels.
Ozuynuk-Ertugrul AS; Ekici B; Erkan AF; Coban N
Lab Med; 2024 May; 55(3):361-372. PubMed ID: 38048807
[TBL] [Abstract][Full Text] [Related]
8. MiR-23a Regulates the Vasculogenesis of Coronary Artery Disease by Targeting Epidermal Growth Factor Receptor.
Wang S; He W; Wang C
Cardiovasc Ther; 2016 Aug; 34(4):199-208. PubMed ID: 27085964
[TBL] [Abstract][Full Text] [Related]
9. miR-22 contributes to the pathogenesis of patients with coronary artery disease by targeting MCP-1: An observational study.
Chen B; Luo L; Zhu W; Wei X; Li S; Huang Y; Liu M; Lin X
Medicine (Baltimore); 2016 Aug; 95(33):e4418. PubMed ID: 27537567
[TBL] [Abstract][Full Text] [Related]
10. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
Brunner S; Kim JO; Methe H
Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
[TBL] [Abstract][Full Text] [Related]
11. Plasma Levels of microRNA-145 Are Associated with Severity of Coronary Artery Disease.
Gao H; Guddeti RR; Matsuzawa Y; Liu LP; Su LX; Guo D; Nie SP; Du J; Zhang M
PLoS One; 2015; 10(5):e0123477. PubMed ID: 25938589
[TBL] [Abstract][Full Text] [Related]
12. Circulating miRNA-33: a potential biomarker in patients with coronary artery disease.
Reddy LL; Shah SAV; Ponde CK; Rajani RM; Ashavaid TF
Biomarkers; 2019 Feb; 24(1):36-42. PubMed ID: 30022694
[TBL] [Abstract][Full Text] [Related]
13. Plasma miR-208b and miR-499: Potential Biomarkers for Severity of Coronary Artery Disease.
Wang W; Li T; Gao L; Li Y; Sun Y; Yao HC
Dis Markers; 2019; 2019():9842427. PubMed ID: 31885748
[TBL] [Abstract][Full Text] [Related]
14. miRNA-93-5p and other miRNAs as predictors of coronary artery disease and STEMI.
O Sullivan JF; Neylon A; McGorrian C; Blake GJ
Int J Cardiol; 2016 Dec; 224():310-316. PubMed ID: 27665403
[TBL] [Abstract][Full Text] [Related]
15. Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease.
Kumar D; Narang R; Sreenivas V; Rastogi V; Bhatia J; Saluja D; Srivastava K
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32033332
[TBL] [Abstract][Full Text] [Related]
16. Impact of Clinical Presentation (Stable Angina Pectoris vs Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction vs ST-Elevation Myocardial Infarction) on Long-Term Outcomes in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents.
Giustino G; Baber U; Stefanini GG; Aquino M; Stone GW; Sartori S; Steg PG; Wijns W; Smits PC; Jeger RV; Leon MB; Windecker S; Serruys PW; Morice MC; Camenzind E; Weisz G; Kandzari D; Dangas GD; Mastoris I; Von Birgelen C; Galatius S; Kimura T; Mikhail G; Itchhaporia D; Mehta L; Ortega R; Kim HS; Valgimigli M; Kastrati A; Chieffo A; Mehran R
Am J Cardiol; 2015 Sep; 116(6):845-52. PubMed ID: 26174605
[TBL] [Abstract][Full Text] [Related]
17. MiR-486 and miR-92a Identified in Circulating HDL Discriminate between Stable and Vulnerable Coronary Artery Disease Patients.
Niculescu LS; Simionescu N; Sanda GM; Carnuta MG; Stancu CS; Popescu AC; Popescu MR; Vlad A; Dimulescu DR; Simionescu M; Sima AV
PLoS One; 2015; 10(10):e0140958. PubMed ID: 26485305
[TBL] [Abstract][Full Text] [Related]
18. Droplet digital PCR as a novel detection method for quantifying microRNAs in acute myocardial infarction.
Robinson S; Follo M; Haenel D; Mauler M; Stallmann D; Tewari M; Duerschmied D; Peter K; Bode C; Ahrens I; Hortmann M
Int J Cardiol; 2018 Apr; 257():247-254. PubMed ID: 29506703
[TBL] [Abstract][Full Text] [Related]
19. Circulating MicroRNA-145 is Associated with Acute Myocardial Infarction and Heart Failure.
Zhang M; Cheng YJ; Sara JD; Liu LJ; Liu LP; Zhao X; Gao H
Chin Med J (Engl); 2017 5th Jan 2017; 130(1):51-56. PubMed ID: 28051023
[TBL] [Abstract][Full Text] [Related]
20. [Clinical implication and association between local and systemic levels of interleukin-1β and interleukin-10 in patients with coronary artery disease].
Yan HB; Li WZ; Zhao HJ; Song L; Zheng B; Zhou P; Liu C
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Feb; 39(2):142-6. PubMed ID: 21426749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
